Free Trial

Enfusion (ENFN) Insider Trading & Ownership

Enfusion logo
$9.05
+0.14 (+1.57%)
(As of 11/1/2024 ET)

Enfusion (NYSE:ENFN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
36.44%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$12.78 M
Get ENFN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enfusion stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ENFN Insider Buying and Selling by Quarter

Enfusion Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/22/2024Matthew CampobassoGeneral CounselSell674$8.95$6,032.30  
6/20/2024Bronwen BastoneInsiderSell18,241$8.11$147,934.51  
6/18/2024Bronwen BastoneInsiderSell10,539$8.17$86,103.63  
6/18/2024Matthew CampobassoGeneral CounselSell1,651$8.17$13,488.67  
6/18/2024Valeria GutowskiCAOSell1,258$8.17$10,277.86  
6/14/2024Deirdre SomersDirectorSell4,629$8.40$38,883.60  
2/29/2024Matthew CampobassoGeneral CounselSell108$8.73$942.84  
2/29/2024Valeria GutowskiCAOSell27$8.73$235.71  
1/10/2024Deirdre SomersDirectorSell1,770$8.65$15,310.50  
1/8/2024Bradley HerringCFOSell1,998$9.23$18,441.54  
1/8/2024Bronwen BastoneInsiderSell391$9.23$3,608.93  
1/8/2024Matthew CampobassoGeneral CounselSell472$9.23$4,356.56  
1/8/2024Oleg MovchanCEOSell1,295$9.23$11,952.85  
12/14/2023Oleg MovchanCEOSell100,000$10.01$1,001,000.00  
12/1/2023Oleg MovchanCEOSell150,000$10.09$1,513,500.00  
11/27/2023Stephen MalherbeMajor ShareholderSell1,000,000$9.86$9,860,000.00  
11/14/2023Dan GromanCTOSell5,000$9.97$49,850.00  
(Data available from 1/1/2013 forward)

ENFN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Enfusion includes Bradley Herring, Bronwen Bastone, Dan Groman, Deirdre Somers, Matthew Campobasso, Oleg Movchan, Stephen Malherbe, Tarek Hammoud, and Valeria Gutowski. Learn more on insiders at ENFN.

36.44% of Enfusion stock is owned by insiders. Learn more on ENFN's insider holdings.

The following insiders have sold ENFN shares in the last 24 months: Bradley Herring ($18,441.54), Bronwen Bastone ($238,784.56), Dan Groman ($514,740.06), Deirdre Somers ($54,194.10), Matthew Campobasso ($24,820.37), Oleg Movchan ($2,526,452.85), Stephen Malherbe ($21,210,000.00), Tarek Hammoud ($22,850,000.00), and Valeria Gutowski ($10,513.57).

Insiders have sold a total of 4,348,553 Enfusion shares in the last 24 months for a total of $47,447,947.05 sold.

Enfusion Key Executives

  • Mr. Oleg Movchan (Age 49)
    CEO & Director
    Compensation: $834.79k
  • Mr. Bradley Herring (Age 53)
    Chief Financial Officer
    Compensation: $574.12k
  • Mr. Neal Pawar (Age 52)
    Chief Operating Officer
    Compensation: $469.39k
  • Mr. Stephen Malherbe
    Managing Partner
  • Ms. Valeria Gutowski (Age 42)
    Chief Accounting Officer
    1 recent trades
  • Mr. Daniel Groman (Age 35)
    Chief Technology Officer
  • Mr. Ignatius Tochukwu Njoku
    Head of Investor Relations
  • Mr. Matthew R. Campobasso (Age 45)
    General Counsel & Corporate Secretary
    2 recent trades
  • Ms. Bronwen Bastone (Age 51)
    Chief People Officer
    Compensation: $566.25k
    2 recent trades
  • Mr. Joseph Defeo
    Global Head of Managed Services Production


This page (NYSE:ENFN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners